SUB1 - SUB1 regulator of transcription Gene

Homo sapiens

Also known as P15; PC4; p14

Gene ID: 10923 | Gene type: protein coding

About SUB1

Cytogenetic location: 5p13.3 Genomic coordinates (GRCh38): 5:32,585,557-32,604,079 (from NCBI)

This gene has 13 transcripts (splice variants) and 228 orthologues. Ubiquitous expression in brain (RPKM 41.5), fat (RPKM 34.4) and 25 other tissues.

Summary

Enables identical protein binding activity; single-stranded DNA binding activity; and transcription coactivator activity. Involved in negative regulation of DNA metabolic process and regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2022]

SUB1 Products(1)

mRNA	Protein	Name
NM_006713.4	NP_006704.3	activated RNA polymerase II transcriptional coactivator p15

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	Reference	Source
enables identical protein binding	IPI IPI: Inferred from physical interaction	16415882	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	9847329	GOA
enables single-stranded DNA binding	IDA IDA: Inferred from direct assay	8062391	GOA
enables transcription coactivator activity	IDA IDA: Inferred from direct assay	8062391	GOA

Biological Process GO Annotation	Evidence	Reference	Source
involved in RNA polymerase II promoter clearance	IDA IDA: Inferred from direct assay	25308091	GOA
involved in negative regulation of DNA duplex unwinding	IDA IDA: Inferred from direct assay	16605275	GOA
involved in negative regulation of DNA metabolic process	IDA IDA: Inferred from direct assay	28369605	GOA
involved in regulation of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	8062391	GOA

Cellular Component GO Annotation	Evidence	Reference	Source
part of transcription regulator complex	IDA IDA: Inferred from direct assay	8062391	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

SUB1 Protein Structure

PC4

0
100
127 a.a.

Protein Preferred Names

Protein Names

activated RNA polymerase II transcriptional coactivator p15

SUB1 homolog, transcriptional regulator

SUB1 Protein-protein interaction Information

Type Cross Intra	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	Reference
Intra	SUB1	P53999	CSTF2	Homo sapiens	P33240-1	Anti Bait CoIP	11389848
Intra	SUB1	P53999	SUB1	Homo sapiens	P53999	X-Ray Diffraction	16415882
Intra	SUB1	P53999	SUB1	Homo sapiens	P53999	Validated Y2H	32296183
Intra	SUB1	P53999	SUB1	Homo sapiens	P53999	Y2H Array	25416956
Intra	SUB1	P53999	SUB1	Homo sapiens	P53999	Y2H Array	32296183
Intra	SUB1	P53999	SUB1	Homo sapiens	P53999	Y2H Prey Pooling	32296183

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant SUB1 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P74650	PC4/SUB1 Protein, Human (His)	P53999 (M1-L127)	≥95%

Related Diseases

Diseases

Alias

Dyskeratosis Congenita, Autosomal Recessive 5

Dyskeratosis Congenita, Autosomal Dominant, 4	DKCB5
Autosomal Dominant Dyskeratosis Congenita 4	DKCA4
Autosomal Recessive Dyskeratosis Congenita 5	Dyskeratosis Congenita, Autosomal Recessive, 5
Dyskeratosis Congenita, Autosomal Dominant 4	Dyskeratosis Congenita, Autosomal Recessive, Type 5

Tinea Manuum

Tinea Manus

Dermatophytosis Of Hand

Cri-Du-Chat Syndrome

5p Deletion Syndrome	5p Partial Monosomy Syndrome
Monosomy 5p	Cat Cry Syndrome
Chromosome 5p Deletion Syndrome	Cri Du Chat Syndrome
5p- Syndrome	5p Minus Syndrome
Chromosome 5p- Syndrome	Chromosome 5 Short Arm Deletion Syndrome
Chromosome 5p Deletion	Deletion 5p
Cri Du Chat	5p Partial Deletion Syndrome
Partial Deletion Of Short Arm Of Chromosome 5 Syndrome

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Clinical Phase

Bioactive Molecules (3)

Cat. No.	Product Name	Effect	Purity	Phase
HY-145119AS	Mindeudesivir hydrobromide	Inhibitor	99.46%	Phase 3
HY-145119S	Mindeudesivir		99.02%	Phase 1
HY-W865379	(S)-Avadomide-d1		/	Phase 1

Pre-clinical Phase

Bioactive Molecules (261)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0762S1	Acetyl-L-carnitine-d3-1 hydrochloride		98.5%	Unkown
HY-153939S	Idasanutlin-d3-1		99.57%	Unkown
HY-B0892S4	Benzyl alcohol-d1		95.05%	Unkown
HY-B0151S2	Pregnenolone-d4-1		99%	Unkown
HY-B0511S	Biotin-d2-1		99.65%	Unkown
HY-B0152S	Adenine-d1	Chemical	99.90%	Unkown
HY-13966S	2-Deoxy-D-glucose-d1		≥98.0%	Unkown
HY-W040193S	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d70		≥99.0%	Unkown
HY-113139S	1-Methylinosine-d3		≥99.0%	Unkown
HY-B0228S	Adenosine-d1		99.72%	Unkown
HY-10162S3	Olaparib-d4-1		98.59%	Unkown
HY-B0389S1	D-Glucose-d1		99.86%	Unkown
HY-B0389S8	D-Glucose-d1-4		≥98.0%	Unkown
HY-N0229S4	L-Alanine-13C,d1		≥98.0%	Unkown
HY-130462S	1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31		≥99.0%	Unkown
HY-100442S1	Paquinimod-d5-1	Inhibitor	98.19%	Unkown
HY-15025S2	Sildenafil-d3-1		99.47%	Unkown
HY-17376S1	Ezetimibe-d4-1		99.26%	Unkown
HY-76025S	1,4-Dibromobenzene-d4		99.90%	Unkown
HY-B0228S8	Adenosine-d1-2		99.72%	Unkown
HY-B0402S	Amantadine-d15		≥98.0%	Unkown
HY-W013504S	1-Bromo-4-(trifluoromethyl)benzene-d4		/	Unkown
HY-W242724	1,4-Dibromo-butane-1,1,2,2,3,3,4,4-d8		/	Unkown
HY-Y1039S1	1-Stearoyl-rac-glycerol-d35		99.04%	Unkown
HY-109541S2	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d9		≥99.0%	Unkown
HY-B0389S7	D-Glucose-d1-3		99.90%	Unkown
HY-W032013S	1-Octanol-d17		99.09%	Unkown
HY-W131797	1-Iodoethane-1,1,2,2,2-d5		≥98.0%	Unkown
HY-107343S1	Docosahexaenoic acid ethyl ester-d5-1		/	Unkown
HY-115702S	1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4		≥99.0%	Unkown
HY-14648S5	Dexamethasone-d3-1		98.02%	Unkown
HY-33948S	1-Amino-2-methylpropan-2-ol-d6		/	Unkown
HY-B0234S4	Estrone-d2-1	Agonist	≥95.0%	Unkown
HY-W009719S	1-Bromo-2,3-dichlorobenzene-d3		/	Unkown
HY-W050145S	Levoglucosan-d7		≥99.0%	Unkown
HY-W097453S2	6-(Methylthio)purine-d3-1		99.56%	Unkown
HY-W768340	Sucrose-13C6-1		/	Unkown
HY-Y0308S	Phosphate dibasic-d1(sodium)		≥99.0%	Unkown
HY-Y0921S2	(±)-1,2-Propanediol-d6		≥99.0%	Unkown
HY-W040193S4	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d4		≥99.0%	Unkown
HY-13956A	(R)-Pioglitazone-d1		/	Unkown
HY-15029S1	(±)-Naproxen-d3-1		/	Unkown
HY-W013376S	Norcyclizine-d8		/	Unkown
HY-10003S	Alfacalcidol-d7	Activator	/	Unkown
HY-100441S1	Treprostinil-13C2,d1	Inhibitor	/	Unkown
HY-10284S3	Linagliptin-d3-1		/	Unkown
HY-10585S4	Valproic acid-d4-1		/	Unkown
HY-10846S1	Delamanid-d4-1		/	Unkown
HY-108506S2	Licarbazepine-d4-1	Inhibitor	/	Unkown
HY-109506S3	DPPC-d9-1		≥99.0%	Unkown
HY-109541S	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d58		/	Unkown
HY-109541S1	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d4		/	Unkown
HY-109541S3	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d13		/	Unkown
HY-109541S4	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d63		/	Unkown
HY-109541S5	1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d67		≥99.0%	Unkown
HY-11018S1	Risperidone-d4-1		/	Unkown
HY-112530S	1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine-d70		/	Unkown
HY-113136S	1-Methylguanosine-d3		/	Unkown
HY-113424AS	1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9		/	Unkown
HY-113482S	1β-Hydroxydeoxycholic acid-d5		/	Unkown
HY-114041S1	Resolvin E1-d4-1		/	Unkown
HY-122272S2	Paroxetine-d6-1	Inhibitor	/	Unkown
HY-122426S1	1-Bromoundecane-d3		/	Unkown
HY-122426S2	1-Bromoundecane-d4		/	Unkown
HY-12650S	Mirogabalin-13C2,d1 (Mixture of Diastereomers)		/	Unkown
HY-12987S2	Pimozide-d4-1	Inhibitor	/	Unkown
HY-130462S1	1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82		/	Unkown
HY-135810S1	Cletoquine-d4-1	Inhibitor	/	Unkown
HY-13593S1	Chlorambucil-d8-1		/	Unkown
HY-13678S1	Meropenem-d6-1	Inhibitor	/	Unkown
HY-14281S2	Trilostane-d3-1		/	Unkown
HY-14648S1	Dexamethasone-d5-1		/	Unkown
HY-14956S1	Nemonoxacin-d3-1	Inhibitor	/	Unkown
HY-151997S	1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3		/	Unkown
HY-152070S1	Demethylmaprotiline-d2-1		/	Unkown
HY-15592S2	Cabotegravir-d3-1	Inhibitor	/	Unkown
HY-15917S1	DL-dithiothreitol-d10-1	Inhibitor	/	Unkown
HY-17386S2	Rosiglitazone-d4-1		/	Unkown
HY-17430S1	Amprenavir-d4-1	Inhibitor	/	Unkown
HY-18341S4	L-Thyroxine-13C6-1		/	Unkown
HY-19696S2	Tauroursodeoxycholate-d4-1	Inhibitor	/	Unkown
HY-23188	Loratadine-d5-1		/	Unkown
HY-34123S	N-(2-Bromoethyl)phthalimide-d4		/	Unkown
HY-34444S	1,1-Dioxothiolan-d8		/	Unkown
HY-41676S	4-Chlorobenzonitrile-d4		/	Unkown
HY-41681S	6-Chloro-1-hexanol-d6		/	Unkown
HY-41700S2	D-Alanine-d1		/	Unkown
HY-50898S3	Lapatinib-d4-1		/	Unkown
HY-66008S1	N-Acetyl mesalazine-d3-1		/	Unkown
HY-66011AS3	Moxifloxacin-d3-1 hydrochloride	Inhibitor	/	Unkown
HY-70057S1	Safinamide-d4-1	Inhibitor	/	Unkown
HY-79779S	1-Bromo-4-(bromomethyl)benzene-d6		99.56%	Unkown
HY-79779S1	1-Bromo-4-(bromomethyl)benzene-d4		/	Unkown
HY-90006S	5-Fluorouracil-d1		99.42%	Unkown
HY-A0042S2	Rufinamide-15N,d2-1		/	Unkown
HY-A0095S1	Flibanserin-d4-1	Modulator	99.28%	Unkown
HY-B0111S1	Drospirenone-d4-1	Agonist	/	Unkown
HY-B0113S1	Omeprazole-d3-1		95.09%	Unkown
HY-B0114S1	Oxcarbazepine-d4-1		/	Unkown
HY-B0141S6	Estradiol-d2-1	Agonist	/	Unkown
HY-B0158S3	Cytidine-d2-1		/	Unkown
HY-B0158S4	Cytidine-d1		/	Unkown
HY-B0196S1	Venlafaxine-d6-1	Inhibitor	/	Unkown
HY-B0197S	Naratriptan-d3		/	Unkown
HY-B0228S7	Adenosine-d1-1		/	Unkown
HY-B0389S18	D-Glucose-13C3-1		/	Unkown
HY-B0389S2	D-Glucose-d12-1		/	Unkown
HY-B0389S23	D-Glucose-d2-1		/	Unkown
HY-B0389S25	D-Glucose-13C,d1		/	Unkown
HY-B0389S3	D-Glucose-d1-1		/	Unkown
HY-B0389S4	D-Glucose-d1-2		/	Unkown
HY-B0400S7	D-Sorbitol-d1-2		/	Unkown
HY-B0400S8	D-Sorbitol-d2-1		/	Unkown
HY-B0402S1	Amantadine-d6		98.10%	Unkown
HY-B0412S4	Estriol-d3-1	Antagonist	/	Unkown
HY-B0451AS3	Dopamine-d2-1 hydrochloride		/	Unkown
HY-B0456S1	Riboflavin-5-Phosphate-13C4,15N2-1		/	Unkown
HY-B0479S1	Thiamphenicol-d3-1		/	Unkown
HY-B0561S2	Spironolactone-d3-1		/	Unkown
HY-B0740S3	Cyclobenzaprine-d3-1 hydrochloride		/	Unkown
HY-B0763S2	Ibudilast-d7-1		/	Unkown
HY-B0896S1	Triacetin-d5	Inhibitor	/	Unkown
HY-B0896S2	Triacetin-d9		/	Unkown
HY-B0901S1	Bromperidol-d4-1	Inhibitor	/	Unkown
HY-B1411S1	i-Inositol-d1		/	Unkown
HY-B1659S3	Glycerol-d1		/	Unkown
HY-B1716S1	L-5-Hydroxytryptophan-d3-1		/	Unkown
HY-D0837S	Imidazole-d4		/	Unkown
HY-G0016S1	N-Acetyl dapsone-d4-1		/	Unkown
HY-N0131S1	Stigmasterol-d5-1		/	Unkown
HY-N0210S11	D-Galactose-d2-1		/	Unkown
HY-N0210S12	D-Galactose-13C,d1		/	Unkown
HY-N0210S5	D-Galactose-d1		/	Unkown
HY-N0210S6	D-Galactose-d1-1		/	Unkown
HY-N0210S7	D-Galactose-d1-2		/	Unkown
HY-N0210S8	D-Galactose-d1-3		/	Unkown
HY-N0215S13	L-Phenylalanine-d1	Antagonist	/	Unkown
HY-N0378S5	D-Mannitol-d1		/	Unkown
HY-N0384S4	Homovanillic acid-d3-1		/	Unkown
HY-N0537S12	Xylose-d1-3		/	Unkown
HY-N0537S13	Xylose-d1-4		/	Unkown
HY-N1380S4	Guaiacol-d4-1		/	Unkown
HY-N1429S2	Taurochenodeoxycholic acid-d4-1 sodium	Inducer	/	Unkown
HY-N7092S18	D-Fructose-d2-1		/	Unkown
HY-P10215	Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2	Inhibitor	/	Unkown
HY-RS13999	SUB1 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W004263S	1-Eicosanol-d41		/	Unkown
HY-W004292S1	1-Undecanol-d4		/	Unkown
HY-W004293S	1-Tridecanol-d27		/	Unkown
HY-W009981S	1-Bromo-2,4-difluorobenzene-d3		/	Unkown
HY-W010265S	Butyrophenone-d5		/	Unkown
HY-W011883S	1,3-Dibromo-5-fluorobenzene-d3		/	Unkown
HY-W012856S	1-Ethyl-3-methylbenzene-d5		/	Unkown
HY-W013053S	Dibenz[a,h]anthracene-d14		/	Unkown
HY-W013948S	1-(2,4-Dinitrophenyl)-2-propylidenehydrazine-d3		/	Unkown
HY-W014286S	1,3-Diphenylurea-d10		/	Unkown
HY-W014431S	1-Bromo-3-chloro-5-fluorobenzene-d3		/	Unkown
HY-W014559S3	1-Bromononane-d4-1		/	Unkown
HY-W015784S	1,4-Benzenedimethanol-d4		/	Unkown
HY-W015824S3	DL-Aspartic acid-13C1		/	Unkown
HY-W015849S	1-Fluoro-4-methoxybenzene-d4		/	Unkown
HY-W016577S3	1-Bromoheptane-d7		/	Unkown
HY-W016577S4	1-Bromoheptane-d1		/	Unkown
HY-W016931S	1-Bromo-4-chlorobutane-d8		/	Unkown
HY-W017554S	1-Chloro-2-methoxybenzene-d3		/	Unkown
HY-W032013S1	1-Octanol-d2		/	Unkown
HY-W032015S3	1-Bromooctane-d4		/	Unkown
HY-W040193S1	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d74		/	Unkown
HY-W040193S2	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d79		/	Unkown
HY-W040193S3	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d83		/	Unkown
HY-W040193S5	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9		≥99.0%	Unkown
HY-W040193S6	1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d13		/	Unkown
HY-W048482S	rU Phosphoramidite-13C2,d1		/	Unkown
HY-W050145S2	Levoglucosan-13C6		/	Unkown
HY-W052227S	Fmoc-DL-Ala-OH-d1		/	Unkown
HY-W087024S	1-Phenylpentane-d5		/	Unkown
HY-W094751S	1-Pyrenamin-d9		/	Unkown
HY-W099504S1	1-Heptanol-d7		/	Unkown
HY-W099504S2	1-Heptanol-d1		/	Unkown
HY-W099521S	1-Chlorooctane-d17		/	Unkown
HY-W101642S	1,3-Diisopropylbenzene-d18		/	Unkown
HY-W105111S	1-Bromo-2,3,5-trichlorobenzene-d2		/	Unkown
HY-W130478S	1-Phenylhexane-d5		/	Unkown
HY-W142175S	1-Butynylbenzene-d5		/	Unkown
HY-Y0093S	NSC 5416-d14		/	Unkown
HY-Y0219S	1,2,4-Triazole-13C2,15N3		/	Unkown
HY-Y0219S1	1,2,4-Triazole-d3		/	Unkown
HY-Y0531S	1-Adamantanol-d15		/	Unkown
HY-Y0727S	1,5-Dibromopentane-d4		/	Unkown
HY-Y0727S1	1,5-Dibromopentane-d10		/	Unkown
HY-Y0860S	1,6-Dibromo-n-hexane-d12		/	Unkown
HY-Y0921S	(±)-1,2-Propanediol-d8		/	Unkown
HY-Y0921S1	(±)-1,2-Propanediol-d2		/	Unkown
HY-Y0921S3	(±)-1,2-Propanediol-13C3		/	Unkown
HY-Y1004S3	1-Decanol-d5		/	Unkown
HY-Y1004S4	1-Decanol-d4		/	Unkown
HY-Y1039S	1-Stearoyl-rac-glycerol-d40		/	Unkown
HY-Y1044S	1,5-Dihydroxypentane-d10		/	Unkown
HY-Y1139S	Pimelic acid-d4		/	Unkown
HY-Y1217S	1-Cyclohexanol-d12		/	Unkown
HY-Y1217S1	1-Cyclohexanol-d11		/	Unkown
HY-Y1309S	1-Naphthol-d8		/	Unkown
HY-Y1641S	1,2-Ethanedithiol-d4		/	Unkown
HY-Y1772S	1-Iodo-4-methylbenzene-d7		/	Unkown
HY-109037S2	Mavacamten-d1	Modulator	/	Unkown
HY-113123S1	LysoPC(14:0/0:0)-d7		/	Unkown
HY-114553S	1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid-d5		/	Unkown
HY-124891S	1-Phenylpyrrole-d9		/	Unkown
HY-131325S	Simeton-d3		/	Unkown
HY-13331S2	Clascoterone-d5-1	Antagonist	/	Unkown
HY-13631ES2	Deruxtecan-d4-1		/	Unkown
HY-141636S	1-PalMitoyl-2-arachidoyllecithin-d9-1		/	Unkown
HY-145473S	1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11		/	Unkown
HY-14649S6	Retinoic acid-d3-1	Agonist	/	Unkown
HY-15780S1	Brexpiprazole-d8-1		96.48%	Unkown
HY-17043S2	Loratadine-d4-1		/	Unkown
HY-19822S1	Elacestrant-d4-1	Inhibitor	/	Unkown
HY-34487S3	1,3-Dimethoxybenzene-d3		/	Unkown
HY-59354S1	1,2-Dihydropyridazine-3,6-dione-3,4,5,6-13C4	Inhibitor	/	Unkown
HY-78004S1	1,2-Diphenylethane-d4		/	Unkown
HY-A0052S	(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4		/	Unkown
HY-B0122SS1	Topiramate-13C6-1		/	Unkown
HY-B0166S8	L-Ascorbic acid-13C6-1		99.15%	Unkown
HY-B0258S1	Gemfibrozil-d6-1		/	Unkown
HY-B0492S	rel-Paroxetine-d4-1 hydrochloride		/	Unkown
HY-B0801S4	Fexofenadine-d3-1	Antagonist	/	Unkown
HY-B1565S	UV Absorber 326-d3		/	Unkown
HY-N2037AS1	Higenamine-d4-1 hydrochloride		/	Unkown
HY-N7092S23	D-Fructose-13C3-1		/	Unkown
HY-N9933S	Tauro-β-muricholic acid-d4-1 sodium		/	Unkown
HY-W004051S	1-Bromo-2-chlorobenzene-d4		≥98.0%	Unkown
HY-W011885S	1-Dodecylpyrrolidin-2-one-d6		/	Unkown
HY-W012477S	1-Hydroxycyclohexyl phenyl ketone-d5		/	Unkown
HY-W012934S	1-Ethylpyrrolidin-2-one-d5		/	Unkown
HY-W016152S	1-Bromo-3-methoxybenzene-d3		/	Unkown
HY-W032013S2	1-Octanol-d2-1	Inhibitor	/	Unkown
HY-W032013S3	1-Octanol-d5	Inhibitor	/	Unkown
HY-W110726S	1-Octen-3-one-d5		/	Unkown
HY-W110726S1	1-Octen-3-one-d3		/	Unkown
HY-W192474S	1-(Furan-2-yl)ethane-1-thiol-d3		/	Unkown
HY-W285163S	1-Cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d8		/	Unkown
HY-W342440S	1,1-Diethoxynonane-d10		/	Unkown
HY-W392083S	(1,3E,5E)-Undeca-1,3,5-triene-d5		/	Unkown
HY-W392083S1	(1,3E,5Z)-Undeca-1,3,5-triene-d5		/	Unkown
HY-W654010	Lurasidone-d8-1 hydrochloride		/	Unkown
HY-W654320	Piperin-d10		/	Unkown
HY-W654353	Tauro-α-muricholic acid-d4-1 sodium	Antagonist	/	Unkown
HY-W654409	1,1,1,3,3,3-Hexafluoropropan-2-ol-d2		/	Unkown
HY-W662572S	Pyroxsulam-d6		/	Unkown
HY-W699983	Imidazole-15N2	Inhibitor	/	Unkown
HY-W756596	1,2-Dioctanoyl-3-chloropropanediol-d5		/	Unkown
HY-W762019S	1,2,3,4,7,8-Hexachloro dibenzo-p-dioxin-13C12		/	Unkown
HY-W777599	(±)-Naproxen-13C,d3-1		/	Unkown
HY-W777649	Oxypurinol-13C,15N2-1	Inhibitor	/	Unkown
HY-Y0045S	2-Acetylthiazole-13C2		/	Unkown
HY-Y0566S	1,4-Diazabicyclo[2.2.2]octane-d12		99.60%	Unkown
HY-Y0678S	1,3,5-Trimethoxybenzene-d3		/	Unkown
HY-Y0743S	1-(Pyridin-2-yl)ethan-1-one-d6		/	Unkown
HY-Y1004S6	1-Decanol-d2-2		/	Unkown
HY-Y1309S1	1-Naphthol-d7		/	Unkown
HY-Y1805S	1,2,3,4-Tetrahydronaphthalene-d4		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	SUB1	MGD	MGI:104811
Rattus norvegicus	SUB1	RGD	RGD:621582
Bos taurus	SUB1	VGNC	VGNC:35454
Macaca mulatta	SUB1	VGNC	VGNC:110431
Others	SUB1	NCBI

Name
Email *

	Sorry, but the email address you supplied was invalid.